Admission characteristics, diagnoses and outcomes of HIV-Infected patients registered in an ambulatory HIV-Care programme in western kenya

East African Medical Journal

Volumn 85, Issue 11, 2008, Pages 523-528

  Siika, A M ^a,b,c   Ayuo, P O ^a,b   Mwangij, A W ^b,d   Sidle, E ^a,b,c   Wools Kaloustian, K ^a,b,c   Kimaiyo, S N ^a,b   Tierney, W M ^b,c,e  

^a MOI UNIVERSITY   (Kenya)

^b Academic Model for Prevention and Treatment of HIV ^*  (Kenya)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LENGTH OF STAY; MALE; MENINGITIS; MIDDLE AGED; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; TUBERCULOSIS;

ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; KENYA; LENGTH OF STAY; MALE; MENINGITIS; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 66149093053     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organisation. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. A Progress Report. Geneva: World Health Organisation; 2007.
2. Galarraga, O., O'Brien, M.E, Gutierrez, J.P., et al Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS. 2007; 21:S97-S103. (Pubitemid 47051755)
3. National AIDS Control Council, Office of the President, Kenya. UNGASS 2008 Country Report for Kenya. NACC, Nairobi. 2008.
4. Lohse, N., Hansen, A.B., Gertoft, J., et al. Improved survival in HIV-infected persons: consequences and perspectives. J. Antimicrob. Chemother. 2007; 60: 461-463. (Pubitemid 47303950)
5. Lima, V.D., Hogg, R.S., Harrigan, P.R., etal. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007; 21:685-692.
6. Schackman, H.R., Gebo, K.A., Walensky, R.P., et al. The lifetime cost or current human immunodeficiency virus care in the United States. Med. Care. 2006; 44:990-997. (Pubitemid 44674030)
7. Stringer J.S., Zulu, I., Levy, J., et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. J. Amer. Med. Assoc. 2006; 296:782-793.
8. Wools-Kaloustian,K.,Kimaiyo,S.,Diero,L.,C.etal. ViabilityandeffectivenessoflargescaleHIVtreatmentinitiativesinsub-SaharanAfrica: ExperiencefromwesternKenya.AIDS.2006;20:41-48.(Pubitemid41818113)
9. Ivers, L.C., Kendrick, D. and Doucette, K. Efficacy of antiretroviral therapy programs in resource poor settings: a meta-analysis of the published literature. Clin. Infect. Dis. 2005; 41:217-224. (Pubitemid 40962502)
10. Laurent, C., Ngom, G., N.F., Ndour, C.T., et al. Longterm benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J. Acquir.Immune Defic. Syndr. 2005; 38:14-17. (Pubitemid 40094112)
11. Coetzee, D., Hildebrand, K., Boulle, A., et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004; 18:887-895. (Pubitemid 38553709)
12. Weidle, P.J., Malamba, S., Mwebaze, R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. 2002; 360:34-40. (Pubitemid 34756490)
13. Nyirenda, M., Hosegood, V., Barnighausen, T., et al. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS 2007; 21: S73-S79. (Pubitemid 350158891)
14. Braitstein, P., Brinkhof, M.W., Dabis, F., et al. Mortality or HIV -1-infected patients in the first year of antiretroviral therapy: comparison between low income and high-income countries. Lancet. 2006; 367: 817-824.
15. UNAIDS: AIDS epidemic update: December 2007. "UNAIDS/07.27E/JC 1322E".
16. Einterz, R.M., Kimaiyo, S., Mengech, H.N.K., et al. Responding to the HIV pandemic: The power of an academic medical partnership. Acad. Med. 2007; 82:812-818. (Pubitemid 47356397)
17. Tierney, W.M., Rotich, J.K., Hannan, T.J., et al. The AMPATH Medical Record System: Creating, implementing, and sustaining an electronic medical record system to support HIV / AIDS care in western Kenya. Medinfo. 2007; 12: 372-376.
18. Siika, A.M., Rotich, J.K.,Simiyu, C.J., etal. An electronic medical record system for ambulatory care of HIV -infected patients in Kenya. Int. J. Med. Informal. 2005; 74: 345-355.
19. Kenya National Census. Central Bureau of Statistics, Ministry of Planning and National Development. 1999.
20. The Kenya Demographic and Health Survey. Central Bureau of Statistics. Ministry of Planning and National Development. 2003
21. Siika, A.M., Wools-Kaloustian, K., Mwangi, A. W., et al. Risk factors for death in HIV-infected adult African patients receiving antiretroviral therapy (under review) East Afri. Med. J.
22. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva. Organisation (WHO/HTM/TB/2007.376).
23. Rana, ES., Hawken, F.P., Mwachari, P., et al. Autopsy study of HIV-I positive and HIV -I negative adult medical patients in Nairobi, Kenya. J. Acquired Immune. Defic. Syndr. 2000; 24:23-29.
24. Harries, A.D. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990; 335:387-390. (Pubitemid 20059358)
25. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centres for Disease Control and Prevention. MMWR Recomm. Rep. 1998; 47(RR-20): 1-58.
26. Golub, J.E., Saraceni, V., Cavalcante, S.C., et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIVinfected patients in Rio de Janeiro, Brazil. AIDS. 2007; 21:1441-1448. (Pubitemid 46988004)
27. Shelburne,S.A.,Visnegarwala,E,Darcourt,J.,etal. Incidenceandriskfactorsforimmunereconstitutioninflammatorysyndromeduringhig hlyactiveantiretroviraltherapy.AIDS2005;19:399-406.(Pubitemid40446186)
28. Murdoch, D.M., Venter, W.D., Feldman, C., et al. Incidence and risk factors for the reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008; 22: 601-610. (Pubitemid 351640593)
29. Bower, M., Nelson, M., Young, A.M., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J. Clin. Oncol. 2005; 23: 52245228. (Pubitemid 46224033)
30. Colebunders,R.,John,L.andHuyst,V. Tuberculosisimmunereconstitutioninflammatorysyndromeincountrieswithlimitedreso urces,Int.J.Tuber.Lung.Dis.2006;10:946-953.(Pubitemid44378968)